|
The government of Saskatchewan has agreed to cover the cost of a new treatment for amyotrophic lateral sclerosis (ALS). Radicava has been added to the Saskatchewan Drug Plan. The medication is taken intravenously and meant to help slow the progression of ALS — commonly referred to as Lou Gehrig's Disease — in its early stages.
|